MHE Seminar Series - Prof Mark Jit

Title: The broader economic impact of vaccines: current developments

Date and time: Wednesday 4 June at 10:00am (AEST)

Registration (essential): https://go.unimelb.edu.au/kv8p

Bio: Professor Mark Jit is the inaugural chair and a professor in the Department of Global and Environmental Health at New York University. He was formerly head of the Department of Infectious Disease Epidemiology & Dynamics and co-director of the Global Health Economics Centre (GHECO) at the London School of Hygiene & Tropical Medicine (LSHTM). He holds honorary appointments at LSHTM as well as the University of Hong Kong (HKU) and the National University of Singapore (NUS).

Professor Jit’s research focuses on epidemiological and economic modeling of vaccines to support evidence-based public health decision making. He has published papers covering a range of vaccine-preventable or potentially vaccine-preventable diseases including COVID-19, measles, HPV, pneumococcus, rotavirus, influenza, Group B Streptococcus, dengue, EV71 and RSV as well as
methodological papers advancing the ways vaccines are evaluated. This work has influenced many of the major changes to immunization policy in countries around the world. Professor Jit has served on a number of expert advisory committees in the UK as well as for international organizations such as the World Health Organization. He also organises or contributes to academic and
professional courses on vaccine modeling, economics and decision science around the world.

Abstract: Economic evaluations of vaccines typically consider the immediate health benefits and cost savings to patients, their households and healthcare providers. These outcomes address the concerns and priorities of the health sector. However, broader socioeconomic evaluations have been developed to address the needs of a variety of stakeholders who influence decisions about vaccines from development to implementation. Some of these are captured by WHO's full value of vaccines framework. This talk discusses recent developments in this area at a time of tighter resources to fund vaccines globally.

Contact: health-economics@unimelb.edu.a